Cargando…

The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis

BACKGROUND: Family with sequence similarity 83 member H antisense RNA 1 (FAM83H-AS1) is a novel long non-coding RNA. Increasing studies have reported that FAM83H-AS1 is abnormally expressed in a variety of tumors and is associated with poor outcome. However, the clinical prognostic significance of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qin, Wang, Jie, Zhong, Pingyong, Mou, Tinggang, Hua, Hao, Liu, Pan, Xie, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059312/ https://www.ncbi.nlm.nih.gov/pubmed/32165862 http://dx.doi.org/10.1186/s12935-020-1148-8

Ejemplares similares

The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis
por: Hua, Hao, et al.
Publicado: (2021)

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation
por: Zhou, Min, et al.
Publicado: (2022)

The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis
por: Zhong, Pingyong, et al.
Publicado: (2021)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis
por: Wang, Jie, et al.
Publicado: (2021)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets
por: Shu, Qiang, et al.
Publicado: (2022)

Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression
por: Chen, Xiao, et al.
Publicado: (2020)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

Evolutionary analysis of FAM83H in vertebrates
por: Huang, Wushuang, et al.
Publicado: (2017)

Novel FAM83H mutations in patients with amelogenesis imperfecta
por: Xin, Wang, et al.
Publicado: (2017)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

The Enamel Phenotype in Homozygous Fam83h Truncation Mice
por: Wang, Shih‐Kai, et al.
Publicado: (2019)

LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis
por: Jia, Jinlin, et al.
Publicado: (2021)

LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
por: Han, Chunyong, et al.
Publicado: (2020)

FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma
por: Li, Junsheng, et al.
Publicado: (2020)

FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis
por: Zhang, Yue, et al.
Publicado: (2022)

LncRNA FAM83H‐AS1 promotes oesophageal squamous cell carcinoma progression via miR‐10a‐5p/Girdin axis
por: Feng, Bo, et al.
Publicado: (2020)

Prognostic significance of FAM83D gene expression across human cancer types
por: Walian, Peter J., et al.
Publicado: (2015)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression via the miR-15a/CCNE2 Axis
por: Liu, Bo, et al.
Publicado: (2021)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression
por: Huang, Hongyu, et al.
Publicado: (2022)

Missense Mutation in Fam83H Gene in Iranian Patients with Amelogenesis Imperfecta
por: POURHASHEMI, S Jalal, et al.
Publicado: (2014)

Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON
por: Kuga, Takahisa, et al.
Publicado: (2016)

Fam83h null mice support a neomorphic mechanism for human ADHCAI
por: Wang, Shih‐Kai, et al.
Publicado: (2015)

Immune implication of FAM83D gene in hepatocellular carcinoma
por: Meng, Tao, et al.
Publicado: (2021)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2
por: Xue, Weinan, et al.
Publicado: (2020)

FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)

A novel FAM83H variant causes familial amelogenesis imperfecta with incomplete penetrance
por: Bai, Rui‐Qi, et al.
Publicado: (2022)

FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
por: Wang, Siwei, et al.
Publicado: (2021)

FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma
por: Hussein, Usama Khamis, et al.
Publicado: (2020)

Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker
por: Yu, Haiyang, et al.
Publicado: (2022)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer
por: Jin, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1n6f427po0iv3i4o4frp7vp0pi